Skip to main content
Log in

Integrating N-alkyl amide in the chalcone framework: synthesis and evaluation of its anti-proliferative potential against AGS cancer cell line

  • Published:
Research on Chemical Intermediates Aims and scope Submit manuscript

Abstract

On the basis of the urgent need to develop innovative and safe anticancer compounds, a series of chalcones, functionalized with various substituents in the aromatic portions and a long N-alkyl amide moiety, were designed and synthesized. The compatibility of novel compounds was firstly evaluated on non-tumoral human gingival fibroblasts (HGFs), secondly, the anti-proliferative effect on an adenocarcinoma gastric cell line (AGS) was measured. Among the chalcones, compound 3, at 50 µM after 48 and 72 h, showed, at the same time, an appreciable capability to counteract tumoral AGS viability and to preserve a high rate of healthy HGFs viability. Cell cycle analysis, performed on AGS cell line with 3 subtoxic dose (30 µM), suggested that the anti-proliferative effect could be related to a cell cycle arrest during the first stage and to an increase in the oxidative stress demonstrated by the significant augmentation of Reactive Oxygen Species release. Collectively, we have demonstrated that chalcone 3 had a potent anti-proliferative potential for the treatment of gastric adenocarcinoma and could be further investigated for new drug development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Scheme 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

Not applicable.

References

  1. S.C. Shah, V. Kayamba, R.M. Peek, D. Heimburger, J. Glob. Oncol. 5, 1 (2019)

    Article  CAS  Google Scholar 

  2. H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA Cancer J. Clin. 71, 209 (2021)

    Article  Google Scholar 

  3. N.N. Pavlova, J. Zhu, C.B. Thompson, Cell Metab. 34, 355 (2022)

    Article  CAS  Google Scholar 

  4. M. Růžička, P. Kulhánek, L. Radová, A. Čechová, N. Špačková, L. Fajkusová, K. Réblová, PLoS ONE 12, e0182377 (2017)

    Article  Google Scholar 

  5. L. Falzone, S. Salomone, M. Libra, Front. Pharmacol. 9, 1300 (2018)

    Article  CAS  Google Scholar 

  6. A.R. Kamal, J.S. Ramaiah, M.J. Dastagiri, D. Bharathi, E.V. Sagar, M.V. Pushpavalli, Med. Chem. Commun. 1, 355 (2010)

    Article  CAS  Google Scholar 

  7. A. Musa, E.M. Mostafa, S.N.A. Bukhari, N.H. Alotaibi, A.H. El-Ghorab, A. Farouk, A.A. Nayl, M.M. Ghoneim, M.A. Abdelgawad, Molecules 27, 1158 (2022)

    Article  CAS  Google Scholar 

  8. M. Sun, M. Yuan, Y. Kang, J. Qin, Y. Zhang, Y. Duan, L. Wang, Y. Yao, J. Enzyme Inhib. Med. Chem. 37, 339 (2022)

    Article  CAS  Google Scholar 

  9. K. Sukumaran, R. Kuttan, J. Ethnopharmacol. 34, 93 (1991)

    Article  CAS  Google Scholar 

  10. H.O. Tawfik, M.A. Shaldam, A. Nocentini, R. Salem, H. Almahli, S.T. Al-Rashood, C.T. Supuran, W.M. Eldehna, J. Enzyme Inhib. Med. Chem. 37, 1043 (2022)

    Article  CAS  Google Scholar 

  11. L. Ni, C.Q. Meng, J.A. Sikorski, Expert Opin. Ther. Pat. 14, 1669 (2014)

    Article  Google Scholar 

  12. C. Echeverria, J.F. Santibañez, O. Donoso-Tauda, C.A. Escobar, R. Ramirez-Tagle, Int. J. Mol. Sci. 10, 221 (2009)

    Article  CAS  Google Scholar 

  13. A.-M. Katsori, D. Hadjipavlou-Litina, Curr. Med. Chem. 16, 1062 (2009)

    Article  CAS  Google Scholar 

  14. T. Akihisa, H. Tokuda, M. Ukiya, M. Iizuka, S. Schneider, K. Ogasawara, T. Mukainaka, K. Iwatsuki, T. Suzuki, H. Nishino, Cancer Lett. 201, 133 (2003)

    Article  CAS  Google Scholar 

  15. F. Moura, M.R.C. de Castro, R.F. Naves, A.J. Araújo, M.C.L. Dos Santos, J.D.B.M. Filho, C. Noda-Perez, F. Terra Martins, C.O. d0 Pessoa, M.O.M. Filho, Anticancer Agents Med. Chem. 22, 2340 (2021)

    Article  Google Scholar 

  16. Y. Wang, L. Li, T. Ma, X. Cheng, D. Liu, Anticancer Agents Med. Chem. 22, 2116 (2021)

    Google Scholar 

  17. U. Shah, A. Patel, S. Patel, M. Patel, A. Patel, S. Patel, S. Patel, R. Maheshwari, A.G. Mtewa, K. Gandhi, Anticancer Agents Med. Chem. 22, 2063 (2021)

    Article  Google Scholar 

  18. A. Joshi, H. Bhojwani, O. Wagal, K. Begwani, U. Joshi, S. Sathaye, D. Kanchan, Anticancer Agents Med. Chem. 22, 328 (2022)

    Article  CAS  Google Scholar 

  19. S. Patil, S. Bhandari, Mini Rev. Med. Chem. 22, 805 (2021)

    Article  Google Scholar 

  20. P.S. de Souza, G.C. Bibá, E.D. Melo, M.F. Muzitano, Nat. Prod. Res. (2021)

  21. T. Constantinescu, C.N. Lungu, Int. J. Mol. Sci. 22, 11306 (2021)

    Article  CAS  Google Scholar 

  22. V. Di Marzo, T. Bisogno, L. De Petrocellis, D. Melck, B.R. Martin, Curr. Med. Chem. 6, 721 (1999)

    Article  Google Scholar 

  23. S. Burstein, R. Salmonsen, Bioorg. Med. Chem. 16, 9644 (2008)

    Article  CAS  Google Scholar 

  24. S. Sarfaraz, V.M. Adhami, D.N. Syed, F. Afaq, H. Mukhtar, Cancer Res. 68, 339 (2008)

    Article  CAS  Google Scholar 

  25. M.I. Chouiter, H. Boulebd, D.M. Pereira, P. Valentão, P.B. Andrade, A. Belfaitah, A.M. Silva, Future Med. Chem. 12, 493 (2020)

    Article  CAS  Google Scholar 

  26. Y.C. Hseu, R.W. Lin, Y.C. Shen, K.Y. Lin, J.W. Liao, V. Thiyagarajan, H.L. Yang, Cancers 12, 2475 (2020)

    Article  CAS  Google Scholar 

  27. F. Alibeiki, N. Jafari, M. Karimi, H. Peeri Dogaheh, Sci. Rep. 7, 2559 (2017)

    Article  Google Scholar 

  28. X.Y. Xiao, M. Hao, X.Y. Yang, Q. Ba, M. Li, S.J. Ni, L.S. Wang, X. Du, Cancer Lett. 302, 69 (2011)

    Article  CAS  Google Scholar 

  29. C.T. Chang, Y.C. Hseu, V. Thiyagarajan, K.Y. Lin, T.D. Way, M. Korivi, J.W. Liao, H.L. Yang, Arch. Toxicol. 91, 3341 (2017)

    Article  CAS  Google Scholar 

  30. B.P. Bandgar, L.K. Adsul, H.V. Chavan, S.N. Shringare, B.L. Korbad, S.S. Jalde, Bioorg. Med. Chem 20, 5649 (2012)

    Article  CAS  Google Scholar 

  31. N.M. Rateb, H.F. Zohdi, Synth. Commun. 39, 2789 (2009)

    Article  CAS  Google Scholar 

  32. L.F. Pisani, G.E. Tontini, C. Gentile, B. Marinoni, I. Teani, N. Nandi, P. Creo, E. Asti, L. Bonavina, M. Vecchi, L. Pastorelli, Int. J. Mol. Sci. 22, 5792 (2021)

    Article  CAS  Google Scholar 

  33. G. Sita, A. Graziosi, P. Hrelia, F. Morroni, Int. J. Mol. Sci. 22, 11201 (2021)

    Article  CAS  Google Scholar 

  34. T. Liu, L. Sun, Y. Zhang, Y. Wang, J. Zheng, J. Biochem. Mol. Toxicol. 36, e22942 (2022)

    CAS  Google Scholar 

  35. M. De Colli, P. Tortorella, M. Agamennone, C. Campestre, F. Loiodice, A. Cataldi, S. Zara, Int. J. Mol. Med. 42, 651 (2018)

    Google Scholar 

  36. A. Ricci, M. Gallorini, D. Del Bufalo, A. Cataldi, I. D’Agostino, S. Carradori, S. Zara, Molecules 27, 957 (2022)

    Article  CAS  Google Scholar 

  37. M.A. Alagöz, Z. Özdemir, M. Uysal, S. Carradori, M. Gallorini, A. Ricci, S. Zara, B. Mathew, Pharmaceuticals 14, 183 (2021)

    Article  Google Scholar 

Download references

Funding

This research received intramural grants from “G. d’Annunzio” University to S.C. (FAR2021).

Author information

Authors and Affiliations

Authors

Contributions

All authors reviewed the manuscript. SC and BM conceived the study, provided funding and wrote the paper; S.Z. and A.R. performed the biological evaluation; RFAA, SD, AV, FSK, RAA, KTK and MAA synthesized and characterized the compounds.

Corresponding authors

Correspondence to Sanal Dev, Bijo Mathew or Simone Carradori.

Ethics declarations

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Consent for publication

Not applicable.

Ethical approval

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 2174 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Azeez, R.F.A., Zara, S., Ricci, A. et al. Integrating N-alkyl amide in the chalcone framework: synthesis and evaluation of its anti-proliferative potential against AGS cancer cell line. Res Chem Intermed 49, 203–220 (2023). https://doi.org/10.1007/s11164-022-04864-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11164-022-04864-w

Keywords

Navigation